Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer (Q36079626)

12 August 2017

Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer (English)

1 reference

12 August 2017

1 reference

Kawa S

1

1 reference

12 August 2017

Tokoo M

2

1 reference

12 August 2017

Hasebe O

3

1 reference

12 August 2017

Hayashi K

4

1 reference

12 August 2017

Imai H

5

1 reference

12 August 2017

Oguchi H

6

1 reference

12 August 2017

Kiyosawa K

7

1 reference

12 August 2017

Furuta S

8

1 reference

12 August 2017

Homma T

9

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 1994

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

70

1 reference

12 August 2017

3

1 reference

12 August 2017

481-486

1 reference

CA 242 is a new tumor marker for pancreatic cancer

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033368

Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033368

Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for Lewis blood group phenotype

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033368

Colorectal carcinoma antigens detected by hybridoma antibodies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033368

Monoclonal antibody defines CA 19-9 in pancreatic juices and sera

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033368

Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033368

Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033368

Comparative study of CA-50 (time-resolved fluoroimmunoassay), Span-1, and CA19-9 in the diagnosis of pancreatic cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033368

The study of the mass screening of persons without symptoms and of the screening of outpatients with gastrointestinal complaints or icterus for pancreatic cancer in japan, using ca19-9 and elastase-1 or ultrasonography

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033368

Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033368

Comparison of serological expression of different epitopes on the CA50-carrying antigen CanAg

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033368

Novel Epitopes on the CA50-Carrying Antigen: Chemical and Immunochemical Studies

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033368

Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033368

Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033368

Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissues: an immunoperoxidase study

23 September 2018

1 reference

12 December 2020

Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibody

1 reference

12 December 2020

Values of CA 19-9 in the serum, pure pancreatic juice, and aspirated pancreatic material in the diagnosis of malignant pancreatic tumor

1 reference

12 December 2020

Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9

1 reference

12 December 2020

Serum CA 19-9 concentrations and computed tomography findings in patients with pancreatic carcinoma

1 reference

12 December 2020

Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis

1 reference

12 December 2020

Loss of Lewis antigen expression on erythrocytes in some cancer patients with high serum CA19-9 levels

1 reference

12 December 2020

The evaluation of CA 19-9 antigen level in the early detection of pancreatic cancer. A prospective study of 866 patients

1 reference

12 December 2020

Behavior of tumor markers CA19.9, CA195, CAM43, CA242, and TPS in the diagnosis and follow-up of pancreatic cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1994.331

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

8080734

1 reference